Ivabradine Hydrochloride CAS 148849-67-6 Puritas >99.5% (HPLC) API Factory

Description:

Nomen chemicum: Ivabradine Hydrochloride

Synonyma: Ivabradine HCl

CAS: 148849-67-6

Puritas: >99.5% (HPLC)

Aspectus: Alba ad Off-White Crystalline pulveris

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Ivabradine Hydrochloride media Cum High puritate
Ivabradine Hydrochloride CAS 148849-67-6
4,5-Dimethoxy-1-Cyanobenzocyclobutaneum CAS 35202-54-1
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutaneum hydrochloridum CAS 866783-13-3
7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one CAS 73942-87-7
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS 148870-57-9
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one CAS 85175-59-3

Chemical Properties:

Nomen chemicum	Ivabradine Hydrochloride
Synonyma	Ivabradine HCl
CAS Number	148849-67-6
CATTUS Number	RF-PI1812
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C27H36N2O5·HCl
M. Pondus	505.05
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White Crystalline pulveris
Lepidium sativum	HPLC/UV obsequium
Puritas / Analysis Methodus	>99.5%
Damnum in Siccatio	<1.00% (sicco in 105℃ in aura electrica flante dryer usque ad constantem pondus)
Humorem content	<1.00%
Residere in Ignition	<0.20%
Max Single immunitas	<0.50%
Totalis immunditias	<0.50%
Optical Isomer	<0.50%
Assay	>99.5%
Metalla gravis	<20ppm
Imprimis Rotationes	+6.5° ~ +8.5° (in fundamento exsiccato, 1% solutio in DMSO)
Test Standard	Enterprise Standard
Consuetudinem	API

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

Ivabradine hydrochloride (CAS: 148849-67-6);In angina agentibus evolvere conatum sine negativis inotropicis et hypotensivis effectibus invitis cum obstructoribus b-adrenergicis et obstructoribus canalis calcii adiunctis, novum genus compositionum cor raterum reducendi, quae specie in nodi sinoatriali (SA) agunt, exploratum est.Hi agentes bradycardici directe secant cum cellula pacemaking nodi SA et hyperpolarisationi reducitur Si primarium currentem pacemagentem.Ivabradine inhibitorem specificum de Si vena per contactum cum f canalibus in parte intracellulari membranae plasmatis evolutum est.Ac per hoc Ivabradine celeritatem diastolicae depolarizationis minuit et rate cor minuit.Probatum est ad anginas firmas chronicas curandas et viabile optionem praebet aegris contraindicationem vel intolerantia obstructorum b.Aestimatio etiam comparata potentiali curationis ischemicae morbi cordis est.